Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
Rigshospitalet · University of Copenhagen · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
962
total citations
- FWCI
- 87.78
- Percentile
- 100%
- References
- 34
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Medicine
- Myocardial infarction
- Culprit
- Internal medicine
- Open label
- ST segment
- Cardiology
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.